Biocon Limited (NSE:BIOCON)
India · Delayed Price · Currency is INR 391.50
-0.15 (-0.04%)
Sep 11, 2026, 3:15 PM IST
Biocon Market Cap
Biocon has a market cap or net worth of 632.66 billion as of September 11, 2026. Its market cap has increased by 30.18% in one year.
Market Cap
632.66B
Enterprise Value
774.07B
Revenue
173.21B
Ranking
n/a
PE Ratio
116.03
Stock Price
391.50
ChartMarket Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 632.66B, an increase of 1,293.13%. That is a compound annual growth rate of 12.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 632.66B | 20.36% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anthem Biosciences | 530.70B |
| OneSource Specialty Pharma | 176.77B |
| Concord Biotech | 151.99B |
| Blue Jet Healthcare | 108.89B |
| Supriya Lifescience | 73.84B |
| Zota Health Care | 38.08B |
| Dishman Carbogen Amcis | 26.26B |
| Panacea Biotec | 23.81B |